The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of cannabis use with real-world time to treatment discontinuation (rwTTD) in patients with advanced cancer initiating immune checkpoint inhibition (ICI).
 
Dylan M. Zylla
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Exact Sciences (Inst); Innate Pharma (Inst); MERCK (Inst); NEKTAR (Inst); Novartis (Inst); Roche (Inst); Seattle Genetics/Astellas (Inst)
 
Greg Knowlton
No Relationships to Disclose
 
Grace Gilmore
No Relationships to Disclose
 
Pamala A. Pawloski
No Relationships to Disclose
 
Talya Salz
No Relationships to Disclose
 
Amit Kulkarni
Stock and Other Ownership Interests - Exact Sciences; Fate Therapeutics; Gilead Sciences; Merck; Mirati Therapeutics; Novavax
Consulting or Advisory Role - Exelixis; Genentech
Research Funding - AstraZeneca
 
Jordan Cowger
No Relationships to Disclose
 
Seth Kuranz
Employment - Forian
Stock and Other Ownership Interests - Forian